This corroborates the concept that AML cells exhibit heightened susceptibility to the concurrent inhibition of BCL2 and nutrient‐sensing pathways, thereby impairing mitochondrial function and biosynthetic ability [58, 59, 60]. The gene discussed is BCL2; the disease is acute myeloid leukemia.